APA (7th ed.) Citation

Gu, X., Wang, W., Wu, W., Zhang, Y., Shao, L., Santarpia, M., . . . Lou, G. (2022). Novel HIVEP1-ALK fusion in a patient with lung adenocarcinoma demonstrating sensitivity to alectinib: A case report. Translational Lung Cancer Research, 11(5), . https://doi.org/10.21037/tlcr-22-288

Chicago Style (17th ed.) Citation

Gu, Xiaodong, et al. "Novel HIVEP1-ALK Fusion in a Patient with Lung Adenocarcinoma Demonstrating Sensitivity to Alectinib: A Case Report." Translational Lung Cancer Research 11, no. 5 (2022). https://doi.org/10.21037/tlcr-22-288.

MLA (9th ed.) Citation

Gu, Xiaodong, et al. "Novel HIVEP1-ALK Fusion in a Patient with Lung Adenocarcinoma Demonstrating Sensitivity to Alectinib: A Case Report." Translational Lung Cancer Research, vol. 11, no. 5, 2022, https://doi.org/10.21037/tlcr-22-288.